As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...

November 22, 2011 (Orlando, Florida) — Results from a small phase 1 study provide some reason for optimism in the treatment of ischemic cardiomyopathy with autologous cardiac stem cells (CSCs) [1]. An ...

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.

The role of assessment of myocardial viability in identifying patients with ischemic cardiomyopathy who might benefit from surgical revascularization remains controversial. Furthermore, although ...

BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...

The Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial was conducted to evaluate the prophylactic implantation of an ICD to prevent sudden death in patients with ...

Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual ...

Among patients with obstructive coronary disease, nonischemic or dual cardiomyopathy is commonly found on cardiac magnetic resonance (CMR) imaging—a combination that is tied to worse clinical outcomes ...

MIAMI, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic ...

Figure 1. Maximum-intensity projections and fusion images of [68 Ga]Ga-FAPI PET/CT from representative patients of different NICM subtypes. PET scans were classified into three columns, including ...